Juvenile Diabetes Research Foundation Canada
STAR RATINGCi's Star Rating is calculated based on the following independent metrics: |
✔+
FINANCIAL TRANSPARENCY
Audited financial statements for current and previous years available on the charity’s website.
A
RESULTS REPORTING
Grade based on the charity's public reporting of the work it does and the results it achieves.
n/r
DEMONSTRATED IMPACT
The demonstrated impact per dollar Ci calculates from available program information.
NEED FOR FUNDING
Charity's cash and investments (funding reserves) relative to how much it spends on programs in most recent year.
54%
CENTS TO THE CAUSE
For a dollar donated, after overhead costs of fundraising and admin/management (excluding surplus) 54 cents are available for programs.
My anchor
OVERVIEW
About Juvenile Diabetes Research Foundation Canada:
Juvenile Diabetes Research Foundation is a 4-star charity with a strong results reporting score. It is financially transparent and its overhead costs are outside Ci’s reasonable range for overhead spending.
Founded in 1974 by parents of children with diabetes, Juvenile Diabetes Research Foundation Canada (JDRF) is the largest funder and advocate for Type 1 diabetes (T1D) research in Canada. It aims to find a cure for T1D and its complications. Type 1 diabetes is an autoimmune disease that stops insulin production, a hormone needed to get energy from food. T1D can lead to life-threatening and debilitating complications. JDRF reports that 300,000 Canadians live with T1D, with a growth of 4.4% annually. Juvenile Diabetes Research Foundation Canada is an affiliate of Juvenile Diabetes Research Foundation International. JDRF has two programs: Research, and Education and Advocacy.
Research grants were $9.0 million in 2022, 83% of JDRF's program spending. In 2022, Juvenile Diabetes Research Foundation Canada funded 48 Canadian research grants including six training awards, 14 clinical trials, and 22 new grants.
Education and Advocacy spending was $1.9 million, 17% of program spending in 2022. The program aims to improve the lives of those living with T1D. JDRF’s Access for All Campaign advocates for affordable and accessible T1D technologies. The initiative resulted in 211 emails to politicians in 2022. The charity’s Kids for a Cure day shares personal stories about T1D with government members. In 2022, the event engaged 76 MPs and senators. JDRF also sent 1,064 care packages to newly diagnosed Canadians in 2022.
In 2021, JDRF launched Campaign to Accelerate, a $100 million research initiative aimed to finally cure T1D. In 2022, the charity received a $10 million donation from the Temerty Foundation, the largest single donation in history to type 1 diabetes research.
My anchor
Results and Impact
Teplizumab, a drug that JDRF helped develop, was approved by the United States Food and Drug Administration (FDA) for people at risk of type 1 diabetes. A clinical trial of the drug showed that its use can delay the onset of the disease by an average of almost three years and in some people, a decade or longer.
As a result of JDRF’s advocacy, Canadians with type 1 diabetes are now automatically qualified for the Disability Tax Credit, saving each individual approximately $1,500 a year.
JDRF’s advocacy efforts in its Access for All campaign resulted in Prince Edward Island, Alberta, and New Brunswick announcing public coverage of continuous glucose monitors (CGMs). Additionally, Manitoba announced the most comprehensive coverage of glucose monitors and insulin pumps, now providing coverage to people of all ages. There are now nine provinces where health care covers the cost of some diabetes technology. The charity reports this will allow thousands of Canadians to better manage their diabetes.
While Ci highlights these key results, they may not be a complete representation of JDRF's results and impact. This charity is not yet rated on impact (n/r).
My anchor
Finances
In 2022, JDRF received $22.1m in donations, up 16% from $19.0m in 2021.
Administrative costs are 12% of revenues and fundraising costs are 34% of donations. This results in total overhead spending of 46%. For every dollar donated, 54 cents go to the cause. This falls outside of Ci’s reasonable range for overhead spending. JDRF has fallen outside of this range since the first year of Ci’s analysis in 2011.
JDRF has reserve funds of $11.6m. The charity could cover a year of annual program costs with current reserves. JDRF has $86k in an endowment fund, but it is not clear whether the funds are donor-endowed.
This charity report is an update that has been sent to JDRF for review. Changes and edits may be forthcoming.
Updated on June 21, 2023 by Kiara Andrade.
Financial Review
Fiscal year ending December
|
2022 | 2021 | 2020 |
|---|---|---|---|
| Administrative costs as % of revenues | 12.4% | 11.2% | 22.3% |
| Fundraising costs as % of donations | 34.0% | 34.9% | 46.8% |
| Total overhead spending | 46.4% | 46.1% | 69.1% |
| Program cost coverage (%) | 102.9% | 135.9% | 212.8% |
Summary Financial StatementsAll figures in $000s |
2022 | 2021 | 2020 |
|---|---|---|---|
| Donations | 22,093 | 18,977 | 12,682 |
| Government funding | 0 | 1,070 | 2,123 |
| Total revenues | 22,093 | 20,048 | 14,804 |
| Program costs | 2,258 | 1,720 | 1,839 |
| Grants | 8,968 | 7,016 | 2,399 |
| Administrative costs | 2,738 | 2,249 | 3,303 |
| Fundraising costs | 7,516 | 6,623 | 5,936 |
| Total spending | 21,480 | 17,609 | 13,477 |
| Cash flow from operations | 613 | 2,439 | 1,327 |
| Capital spending | 71 | 42 | 28 |
| Funding reserves | 11,555 | 11,877 | 9,095 |
Note: To report on a cash basis, Ci included deferred revenues, affecting revenue by $81k in F2022, $2.6m in F2021, and $611k in F2020. Ci used government funding amounts recorded in the charity’s T3010 filing with the CRA, which was backed out of donations. The charity's T3010 filings for F2022 are not yet available, so this adjustment has not been made for F2022. Ci removed grants from program costs and reported the amounts separately. Ci removed amortization from administrative costs.
Salary Information
$350k + |
0 |
$300k - $350k |
1 |
$250k - $300k |
1 |
$200k - $250k |
1 |
$160k - $200k |
4 |
$120k - $160k |
3 |
$80k - $120k |
0 |
$40k - $80k |
0 |
< $40k |
0 |
Information from most recent CRA Charities Directorate filings for F2021
My anchor
Comments & Contact
Comments added by the Charity:
Thanks to the continued commitment of our supporters and partners, JDRF Canada invested $8.8 million CDN in T1D research in 2022, which was amplified by a further $2.2M from research partnerships including with Canada’s federal funding agency for health research, the Canadian Institutes of Health Research (CIHR). In 2017, JDRF Canada and CIHR established the JDRF-CIHR Partnership to Defeat Diabetes, each contributing $15M, for a total $30M investment to fund T1D research in Canada. This partnership was then renewed in 2021 with an additional $15M from the federal government and matched by JDRF Canada. Funds from this round of the partnership will be allocated to research beginning in early 2023 and is anticipated to finish in 2027. This brings the total investment in T1D research through this partnership to $60M - $30M from the Government of Canada (through CIHR) and $30M from JDRF Canada. Dollars committed by CIHR cannot be counted in our financial statements, even though this is a partnership secured and driven by JDRF Canada.
JDRF Canada funds T1D research in two main areas: Cures (including screening, disease-modifying therapies, and cell therapy) and Improving Lives (including mental health, complications, adjunctive therapies, and devices). JDRF Canada amplifies their impact through partnerships, with over $2.2M of our research funds in 2022 being matched dollar-to-dollar from other funders, including CIHR.
Charity Contact
This email address is being protected from spambots. You need JavaScript enabled to view it. Tel: 647.789.2000